Purchases and Sales Made in Q2 2022 in Crinetics Pharmaceuticals, Inc. (CRNX)
This table provides information about the institutional ownership of Crinetics Pharmaceuticals, Inc. (CRNX) during Q2 2022. The information is specifically focused on institutions that hold shares of Crinetics Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 12, 2022
Q2 2022
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-33.4K- 42.7% |
$550K - $922K
|
44.8K
$2.51M
|
|
|
Aug 03, 2022
Q2 2022
|
Simplex Trading, LLC
|
SELL
|
- |
-37.6K- 98.55% |
$620K - $1.04M
|
552
$30.9K
|
|
|
Aug 12, 2022
Q2 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-43.6K- 44.57% |
$720K - $1.21M
|
54.3K
$3.04M
|
|
|
Aug 10, 2022
Q2 2022
|
Ubs Group Ag
|
SELL
|
- |
-49.3K- 72.0% |
$813K - $1.36M
|
19.2K
$1.08M
|
|
|
Aug 11, 2022
Q2 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-50.8K- 62.21% |
$838K - $1.41M
|
30.9K
$1.73M
|
|
|
Aug 15, 2022
Q2 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-65.2K- 83.74% |
$1.08M - $1.8M
|
12.7K
$710K
|
|
|
Aug 15, 2022
Q2 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-74K- 61.3% |
$1.22M - $2.05M
|
46.7K
$2.62M
|
|
|
Aug 15, 2022
Q2 2022
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-80KClosed |
$1.32M - $2.21M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Ghost Tree Capital, LLC
New York, NY |
SELL
|
- |
-85KClosed |
$1.4M - $2.35M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Altium Capital Management LP
New York, NY |
SELL
|
- |
-204KClosed |
$3.36M - $5.64M
|
0
$0
|
|
|
Aug 11, 2022
Q2 2022
|
Versant Venture Management, LLC
San Francisco, CA |
SELL
|
- |
-410KClosed |
$6.77M - $11.3M
|
0
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-489K- 31.7% |
$8.06M - $13.5M
|
1.05M
$59M
|
|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-553K- 85.01% |
$9.11M - $15.3M
|
97.5K
$5.46M
|